Essential updates 2022-2023: Surgical and adjuvant therapies for locally advanced colorectal cancer

Ann Gastroenterol Surg. 2024 Aug 19;8(6):977-986. doi: 10.1002/ags3.12853. eCollection 2024 Nov.

Abstract

Pivotal articles that had been published between 2022 and 2023 on surgical and perioperative adjuvant treatments for locally advanced colorectal cancer (CRC) were reviewed. This review focuses on new evidence in the following areas: optimization of surgical procedures for colon cancer, including the optimal length of bowel resection and use of the no-touch isolation technique; minimally invasive surgery for rectal cancer, such as laparoscopic transanal total mesorectal excision and robotic surgery; neoadjuvant treatments for rectal cancer, including total neoadjuvant therapy; neoadjuvant chemotherapy for colon cancer; and postoperative adjuvant chemotherapy for Stage II and III colon cancer. Although the current understanding may not enable perfect decision-making for patients and medical professionals, ongoing advancements are expected to result in more effective personalized treatment plans, ultimately improving the prognosis and quality of life of patients.

Keywords: adjuvant therapy; colorectal cancer; minimally invasive surgery; neoadjuvant therapy; surgical treatment.

Publication types

  • Review